CN1872199A - 一种中药组合物及其制备方法 - Google Patents
一种中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN1872199A CN1872199A CN 200510073191 CN200510073191A CN1872199A CN 1872199 A CN1872199 A CN 1872199A CN 200510073191 CN200510073191 CN 200510073191 CN 200510073191 A CN200510073191 A CN 200510073191A CN 1872199 A CN1872199 A CN 1872199A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- chinese medicine
- crude drug
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 116
- 239000000203 mixture Substances 0.000 title claims description 60
- 238000002360 preparation method Methods 0.000 title description 30
- 206010039083 rhinitis Diseases 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 8
- 230000001154 acute effect Effects 0.000 claims abstract description 7
- 201000009151 chronic rhinitis Diseases 0.000 claims abstract description 5
- 201000009240 nasopharyngitis Diseases 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 93
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 91
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 68
- 239000007788 liquid Substances 0.000 claims description 57
- 238000012360 testing method Methods 0.000 claims description 52
- 229940079593 drug Drugs 0.000 claims description 46
- 239000000796 flavoring agent Substances 0.000 claims description 30
- 235000019634 flavors Nutrition 0.000 claims description 30
- 239000013558 reference substance Substances 0.000 claims description 30
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 29
- 241000628997 Flos Species 0.000 claims description 28
- 241000903946 Clematidis Species 0.000 claims description 26
- 239000009636 Huang Qi Substances 0.000 claims description 26
- 239000009670 cang er zi wan Substances 0.000 claims description 25
- 239000002994 raw material Substances 0.000 claims description 19
- 238000004809 thin layer chromatography Methods 0.000 claims description 18
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 claims description 17
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 11
- 238000004821 distillation Methods 0.000 claims description 11
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 claims description 10
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims description 8
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims description 8
- 229960003321 baicalin Drugs 0.000 claims description 8
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 238000001556 precipitation Methods 0.000 claims description 7
- 235000014666 liquid concentrate Nutrition 0.000 claims description 6
- 206010001076 Acute sinusitis Diseases 0.000 claims description 4
- 206010009137 Chronic sinusitis Diseases 0.000 claims description 4
- -1 Radix Platycodonis Substances 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- 208000027157 chronic rhinosinusitis Diseases 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000006196 drop Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 7
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 244000111489 Gardenia augusta Species 0.000 abstract description 2
- 235000018958 Gardenia augusta Nutrition 0.000 abstract description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 79
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 16
- 239000007963 capsule composition Substances 0.000 description 15
- 239000007921 spray Substances 0.000 description 14
- 239000012669 liquid formulation Substances 0.000 description 13
- 239000012567 medical material Substances 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 201000009890 sinusitis Diseases 0.000 description 11
- 238000000605 extraction Methods 0.000 description 10
- 239000000287 crude extract Substances 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 6
- 229960003957 dexamethasone Drugs 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000000242 pagocytic effect Effects 0.000 description 6
- 238000003809 water extraction Methods 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 241001289346 Asarum himalaicum Species 0.000 description 3
- 241000202726 Bupleurum Species 0.000 description 3
- 206010018691 Granuloma Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 241000218378 Magnolia Species 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 241000213006 Angelica dahurica Species 0.000 description 2
- 241001289295 Asarum sieboldii Species 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 241000345998 Calamus manan Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 244000274050 Platycodon grandiflorum Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 2
- PIRWNASAJNPKHT-SHZATDIYSA-N pamp Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(C)C)C1=CC=CC=C1 PIRWNASAJNPKHT-SHZATDIYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 235000012950 rattan cane Nutrition 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- 241000758795 Aristolochiaceae Species 0.000 description 1
- 241001472196 Asarum heterotropoides Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241001132282 Bupleurum malconense Species 0.000 description 1
- 241001513903 Bupleurum microcephalum Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000260447 Clematis armandii Species 0.000 description 1
- 241000786785 Clematis montana Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 241000007358 Magnolia biondii Species 0.000 description 1
- 240000005819 Magnolia denudata Species 0.000 description 1
- 235000016094 Magnolia denudata Nutrition 0.000 description 1
- 241001673966 Magnolia officinalis Species 0.000 description 1
- 241000007370 Magnolia sprengeri Species 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 244000280293 Mentha haplocalyx Species 0.000 description 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- JMUFJNCIWRHXIR-UHFFFAOYSA-N O.OC.OC=O.CCOC(C)=O Chemical compound O.OC.OC=O.CCOC(C)=O JMUFJNCIWRHXIR-UHFFFAOYSA-N 0.000 description 1
- 235000006751 Platycodon Nutrition 0.000 description 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- KIBLEPZGKRYXBB-UHFFFAOYSA-N butan-2-one ethyl acetate formic acid hydrate Chemical compound O.OC=O.CCC(C)=O.CCOC(C)=O KIBLEPZGKRYXBB-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002674 endoscopic surgery Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000003108 foot joint Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- DEDOPGXGGQYYMW-UHFFFAOYSA-N molinate Chemical compound CCSC(=O)N1CCCCCC1 DEDOPGXGGQYYMW-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229930189914 platycodon Natural products 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Abstract
Description
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100731915A CN100415255C (zh) | 2005-06-01 | 2005-06-01 | 一种中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100731915A CN100415255C (zh) | 2005-06-01 | 2005-06-01 | 一种中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1872199A true CN1872199A (zh) | 2006-12-06 |
CN100415255C CN100415255C (zh) | 2008-09-03 |
Family
ID=37482908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100731915A Active CN100415255C (zh) | 2005-06-01 | 2005-06-01 | 一种中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100415255C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102363039A (zh) * | 2011-11-14 | 2012-02-29 | 王敬祥 | 一种治疗鼻炎的中药 |
CN104984042A (zh) * | 2015-07-23 | 2015-10-21 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗急慢性鼻炎、鼻窦炎的中药制剂及其制备方法 |
CN106075234A (zh) * | 2016-08-08 | 2016-11-09 | 田丰 | 一种双辛鼻炎丸 |
CN113080746A (zh) * | 2021-03-31 | 2021-07-09 | 成都华神科技集团股份有限公司 | 一种预防和/或治疗鼻炎的湿纸巾及其制备方法 |
CN113080546A (zh) * | 2021-03-31 | 2021-07-09 | 成都华神科技集团股份有限公司 | 一种治疗和/或预防鼻炎的口罩及其制备方法 |
WO2023249261A1 (ko) * | 2022-06-23 | 2023-12-28 | 한국 한의학 연구원 | 색소가 제거된 치자 추출물을 유효성분으로 포함하는 비염의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1167445C (zh) * | 2001-08-15 | 2004-09-22 | 李咸珠 | 一种治疗鼻炎、鼻窦炎的中草药制剂 |
-
2005
- 2005-06-01 CN CNB2005100731915A patent/CN100415255C/zh active Active
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102363039A (zh) * | 2011-11-14 | 2012-02-29 | 王敬祥 | 一种治疗鼻炎的中药 |
CN102363039B (zh) * | 2011-11-14 | 2013-09-11 | 济南伟传信息技术有限公司 | 一种治疗鼻炎的中药 |
CN104984042A (zh) * | 2015-07-23 | 2015-10-21 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗急慢性鼻炎、鼻窦炎的中药制剂及其制备方法 |
CN106075234A (zh) * | 2016-08-08 | 2016-11-09 | 田丰 | 一种双辛鼻炎丸 |
CN113080746A (zh) * | 2021-03-31 | 2021-07-09 | 成都华神科技集团股份有限公司 | 一种预防和/或治疗鼻炎的湿纸巾及其制备方法 |
CN113080546A (zh) * | 2021-03-31 | 2021-07-09 | 成都华神科技集团股份有限公司 | 一种治疗和/或预防鼻炎的口罩及其制备方法 |
CN113080546B (zh) * | 2021-03-31 | 2023-12-08 | 成都华神科技集团股份有限公司 | 一种治疗和/或预防鼻炎的口罩及其制备方法 |
WO2023249261A1 (ko) * | 2022-06-23 | 2023-12-28 | 한국 한의학 연구원 | 색소가 제거된 치자 추출물을 유효성분으로 포함하는 비염의 예방, 개선 또는 치료용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
CN100415255C (zh) | 2008-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100339085C (zh) | 治疗心脑血管疾病的中药组合物 | |
CN1600318A (zh) | 一种治疗心脑血管疾病的中药组合物 | |
CN1872199A (zh) | 一种中药组合物及其制备方法 | |
CN1768854A (zh) | 一种具有补脾益肠作用的中药胶囊制剂 | |
CN1285358C (zh) | 一种药物组合物及其制备方法和质量控制方法 | |
CN1919248A (zh) | 一种治疗心脑血管病的中药制剂 | |
CN1803787A (zh) | 贯叶金丝桃总黄酮提取物、其制备及应用 | |
CN1919240A (zh) | 治疗心脑血管疾病的中药 | |
CN100336544C (zh) | 一种具有健肤美容作用的中药组合物及其制备方法 | |
CN1254266C (zh) | 感冒胶囊及其制备方法 | |
CN1562113A (zh) | 一种治疗慢性盆腔炎的药物及其制备方法 | |
CN1820770A (zh) | 一种治疗中风的中药组合物及其制备方法 | |
CN1903238A (zh) | 一种中药提取物、制剂及其制备方法与用途 | |
CN1853688A (zh) | 一种治疗心脑血管病、缺血性中风的中药制剂及其制备方法 | |
CN1258372C (zh) | 治疗肠易激综合症的中药组合物及其制备方法 | |
CN1857385A (zh) | 一种治疗颈椎病的药物组合物及其制备方法 | |
CN1194743C (zh) | 一种治疗类风湿性关节炎的中药组合物及其制备方法和质量控制方法 | |
CN1919238A (zh) | 一种治疗心脑血管病的药物 | |
CN1919252A (zh) | 一种治疗心脑血管疾病的药物 | |
CN1565611A (zh) | 一种治疗肩周炎的中药组合物及其制备方法 | |
CN1919247A (zh) | 一种治疗心脑血管病的中药 | |
CN1509729A (zh) | 咽宁搭档 | |
CN1265807C (zh) | 含有胡麻苷的黄酮类提取物及其应用 | |
CN1650976A (zh) | 复方雪莲软胶囊及其制备工艺 | |
CN1919237A (zh) | 治疗心脑血管疾病的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Chengdu Chinese Medicine University Huasun Pharmaceutical Co., Ltd. Assignor: Pharmaceutical Factory, Chengdu Huashen Group Corp., Ltd. Contract record no.: 2010510000136 Denomination of invention: Chinese medicine composition and its preparing method Granted publication date: 20080903 License type: Exclusive License Open date: 20061206 Record date: 20101220 |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 610000 Sichuan city of Chengdu Province Southwest Economic Development Zone Jinhua Road two No. 3 Patentee after: Chengdu Taihe health technology group Limited by Share Ltd Huashen pharmaceutical factory Address before: 610023 Sichuan city of Chengdu Province Southwest Economic Development Zone Jinhua Road 2 No. 3 Patentee before: Pharmaceutical Factory, Chengdu Huashen Group Corp., Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Pharmaceutical Factory, Chengdu Huashen Group Corp., Ltd. Document name: Notification of Passing Examination on Formalities |
|
CP01 | Change in the name or title of a patent holder |
Address after: 610000 Sichuan city of Chengdu Province Southwest Economic Development Zone Jinhua Road two No. 3 Patentee after: Pharmaceutical factory of Chengdu Huashen Technology Group Co., Ltd Address before: 610000 Sichuan city of Chengdu Province Southwest Economic Development Zone Jinhua Road two No. 3 Patentee before: Chengdu Taihe health technology group Limited by Share Ltd Huashen pharmaceutical factory |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201026 Address after: 611731 No.101, 1st floor, building 2, no.1168 Shuxin Avenue, Chengdu high tech Zone (West District), Sichuan Province Patentee after: Chengdu Huashen Technology Group Co.,Ltd. Address before: 610000 Sichuan city of Chengdu Province Southwest Economic Development Zone Jinhua Road two No. 3 Patentee before: Pharmaceutical factory of Chengdu Huashen Technology Group Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: CHENGDU UNIVERSITY OF TCM HUASUN PHARMACEUTICAL Co.,Ltd. Assignor: PHARMACEUTICAL FACTORY OF CHENGDU HUASUN GROUP Inc.,Ltd. Contract record no.: 2010510000136 Date of cancellation: 20211014 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20061206 Assignee: Pharmaceutical factory of Chengdu Huashen Technology Group Co.,Ltd. Assignor: Chengdu Huashen Technology Group Co.,Ltd. Contract record no.: X2021990000757 Denomination of invention: The invention relates to a traditional Chinese medicine composition and a preparation method thereof Granted publication date: 20080903 License type: Exclusive License Record date: 20211207 |
|
EE01 | Entry into force of recordation of patent licensing contract |